MicroPort Navibot Receives 510(K) Clearance for its SkyWalker™ Robot-Assisted Platform for Orthopedic Applications

MicroPort Navibot has received 510(K) clearance from the Food and Drug Administration (FDA) in the United States for the SkyWalker™ System, the company’s first robot-assisted platform for orthopedic applications. The SkyWalker™ System will initially offer a robotically assisted total knee replacement solution that is compatible with the Evolution® Medial-Pivot Total Knee System. Designed based on clinical needs, MicroPort…

Read More

Spineology® Launches First Fully Endoscopic, Single-Tubular Retractor Fusion System: OptiLIF® Endo

Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces another milestone with the limited launch of OptiLIF® Endo. This innovative, ultra-MIS system requires only one tubular retractor to seamlessly integrate endoscopes and endoscopic equipment into lumbar interbody fusion procedures. The OptiMesh® Multiplanar Expandable Implant enables this single tube system to employ the smallest diameter tubular retractor of…

Read More

Cognito Therapeutics Announces Proprietary Gamma Sensory Stimulation for 6-Months Reduces White Matter Atrophy in Alzheimer’s Disease Patients

Cognito Therapeutics, announced that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for patients with Alzheimer’s Disease, according to new data presented at the Alzheimer’s Association International Conference 2022. Alzheimer’s Disease (AD) is the most common form of dementia. Although white matter atrophy is observed…

Read More

Rapid Medical Gains FDA Clearance for the Smallest & Only Adjustable Thrombectomy Device

Rapid Medical, a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER™13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. TIGERTRIEVER 13 is the smallest revascularization device in the world to date and is designed to remove thrombus from delicate brain blood vessels during an…

Read More

Caption Health Receives CE Mark for Caption AI™ Technology Platform

Caption Health, the leader in using AI and services to improve heart ultrasound access, announced that it has received a CE Mark for its Caption AI™ technology platform. This certification represents the first step in making Caption Health’s industry-leading technology platform available outside the US, and highlights the company’s strong clinical and regulatory track record…

Read More

How and Why Your Resume Should be for TWO different audiences: Man and Machine

Resume writing advice is everywhere online. There are guides that proudly proclaim how important resume titles are, or how your Times New Roman font is preventing you from finding your next job, to guides that insist you use a professional service to “set yours apart from the rest.” The popular conception is that there’s stack…

Read More

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System

Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch® Ventricular Restoration System. Currently being evaluated in the CORCINCH-HF pivotal clinical trial, the AccuCinch System is designed to provide a minimally invasive treatment option for…

Read More

Samsara Vision Announces First U.S. Surgeries of the SING IMT™ (Smaller-Incision New-Generation Implantable Miniature Telescope), for Age-Related Macular Degeneration as part of the CONCERTO Study

Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visual prosthetic devices, announced the completion of the first U.S. surgeries of its SING IMT™ (Smaller-Incision New-Generation Implantable Miniature Telescope), as part of the CONCERTO clinical study, a U.S.-based Food and Drug Administration (FDA)…

Read More

What’s Your Six Word Story?

Six Word Story

If you ever studied English literature, it’s almost certain that you’ve heard of a Six Word Story; A contributing method to Ernest Hemingway’s Iceberg theory in which the writer uses only six words to tell an entire story. You may have even written a few. According to legend, Hemingway constructed the six-word story at lunch…

Read More

annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances

annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer. With the new appointments, annalise.ai expects to further accelerate its global market presence and entry into the US…

Read More